ReviewInternational journal of women's health2026
Leprosy in Pregnancy: A Systematic Review of Maternal Characteristics, Complications, and Neonatal Outcomes.
Review in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Nearly 40% of leprosy cases occur in females. Although relatively uncommon in pregnancy, immunological changes during gestation and the puerperium may exacerbate leprosy and influence maternal and neonatal outcomes. To date, no systematic review has synthesized the evidence on leprosy in pregnancy. Purpose: To describe maternal clinical and obstetric characteristics, pregnancy complications, neonatal outcomes, and laboratory findings in pregnant women with leprosy. Methods: We systematically searched electronic databases from inception to August 2025 for studies reporting leprosy in pregnancy or puerperium using specific terms and inclusion/exclusion criteria. Data were extracted and presented descriptively. Results: Eighteen case reports and case series described a total of 21 individual patients, while an additional eight original articles were included. Most patients were aged 20-39 years (85.7%), with multibacillary leprosy predominating (80.9%) of cases. Erythema nodosum leprosum was more frequent during pregnancy (14.3%), while reversal reactions predominated in the puerperium (9.5%). Leprosy in pregnancy was most frequently reported in the third trimester (52.4%). Cesarean section was slightly more frequent than vaginal delivery (33.3% vs 23.8%). Overall, maternal and neonatal outcomes were generally favorable, although complications included intrauterine growth restriction, hematologic abnormalities, preterm delivery, neonatal skin discoloration, and hyperbilirubinemia. One infant was diagnosed with leprosy at six months. Slit-skin smears were occasionally positive with a high bacteriological index, and acid-fast bacilli were detected in the placentas of mothers with leprosy. Conclusion: Leprosy in pregnancy most often affects women of reproductive age with the multibacillary type, typically presenting in the third trimester. While maternal and neonatal outcomes are generally favorable, complications may occur, underscoring the importance of continuing multidrug therapy with close monitoring. Further multicenter studies are required to better define transmission risks and optimize management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.